Geeta Chacko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Geeta Chacko has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
Ari G. Chacko
Department of Neurological Sciences, Christian Medical College, Vellore, India
6 shared publications- Abhijit Goyal-Honavar
Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India
4 shared publications - Rajesh Balakrishnan
Christian Medical College Vellore
4 shared publications Sauradeep Sarkar
Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India
4 shared publicationsVedantam Rajshekhar
4 shared publicationsAri George Chacko
Department of Neurological Sciences, Christian Medical College, Vellore, India
3 shared publications
Latest Publications
- Open Access
- 21 May 2025
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 37, 100602
Neuromelioidosis outbreak in Tamil Nadu, India: an investigation of transmission with genomic insights
- 21 May 2025
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 37, 100602
Open AccessNeuromelioidosis outbreak in Tamil Nadu, India: an investigation of transmission with genomic insights
- Open Access
- 5 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123421
Recurrence After Microsurgical Excision of Third Ventricular Colloid Cysts in a Contemporary Cohort of 84 Patients
- 5 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123421
Open AccessRecurrence After Microsurgical Excision of Third Ventricular Colloid Cysts in a Contemporary Cohort of 84 Patients
- Open Access
- 25 August 2024
- Published by Wiley in Brain Pathology
- Vol. 35 (1) , e13298
Practical approaches to diagnosing PitNETs/adenomas based on cell lineage
The evolution of classification systems of pituitary adenomas (now PitNETs) has culminated in the use of transcription factor (TF) immunohistochemistry (IHC), forming a cell lineage‐based system. However, several issues remain to be addressed, including the additional financial and logistic burden of undertaking the complete array of anterior pituitary hormones and TF IHC. To that end, several groups have suggested algorithms to minimise the number of tests performed, with varying levels of diagnostic accuracy. Although the proportion of null cell tumours has decreased following the use of TFs, “multilineage” tumours have been reported and characterised using transcriptomic signatures, most prominently the PIT1‐SF1 co‐expressing PitNETs, which do not bear a position in the present system of classification. In this review, we examine the proposed practical approaches to the diagnosis of PitNETs. We review the literature on reported PitNET types that challenge the existing classification system, such as those that express multiple TFs, with their potential clinical implications. Finally, we assess limitations in the present system, such as the lack of a standardised system for IHC interpretation, that need to be addressed in the future.
- 25 August 2024
- Published by Wiley in Brain Pathology
- Vol. 35 (1) , e13298
Open AccessPractical approaches to diagnosing PitNETs/adenomas based on cell lineage
The evolution of classification systems of pituitary adenomas (now PitNETs) has culminated in the use of transcription factor (TF) immunohistochemistry (IHC), forming a cell lineage‐based system. However, several issues remain to be addressed, including the additional financial and logistic burden of undertaking the complete array of anterior pituitary hormones and TF IHC. To that end, several groups have suggested algorithms to minimise the number of tests performed, with varying levels of diagnostic accuracy. Although the proportion of null cell tumours has decreased following the use of TFs, “multilineage” tumours have been reported and characterised using transcriptomic signatures, most prominently the PIT1‐SF1 co‐expressing PitNETs, which do not bear a position in the present system of classification. In this review, we examine the proposed practical approaches to the diagnosis of PitNETs. We review the literature on reported PitNET types that challenge the existing classification system, such as those that express multiple TFs, with their potential clinical implications. Finally, we assess limitations in the present system, such as the lack of a standardised system for IHC interpretation, that need to be addressed in the future.
- Open Access
- 7 September 2022
- Published by Medknow in Urology Annals
- Vol. 14 (4) , 365-371
Adult renal angiomyolipomas: A retrospective analysis of the histological subtypes and their clinicoradiological correlates
Background: Renal angiomyolipomas (AMLs) are rare, benign mesenchymal tumors of the kidney. Asian data on the prevalence of the subtypes of AMLs and their association with tuberous sclerosis are sparse prompting us to evaluate the clinicopathological characteristics of these tumors. Materials and Methods: We included cases diagnosed from 2001 to 2021 extracting demographic details, clinical presentation, syndromic association with tuberous sclerosis, and preoperative clinicoradiological features from the electronic medical records. Results: Ninety-five cases of adult renal AML were diagnosed among 2402 renal tumors, a prevalence of 3.95%. Forty tumors (42%) were detected incidentally; two patients had life-threatening retroperitoneal hemorrhage. Tuberous sclerosis complex (TSC) was associated with ten cases (10.5%). These patients were a decade younger than those in the non-TSC group (P = 0.008) and had bilateral, multiple, and larger tumors (P = 0.0009, 0.001, and 0.047, respectively). Microscopically, classic and epithelioid subtypes were seen in 87 (91.6%) and 8 cases (8.4%), respectively. Hemorrhage was more common in the epithelioid subtype (P = 0.13). HMB-45, melan-A, and smooth muscle actin immunohistochemistry were useful in cases which lacked the prototypical classic histology and for confirming a diagnosis of epithelioid AML. Conclusions: The prevalence of renal AML in our series was four times higher, and the mean age at diagnosis was a decade earlier than that reported in Western literature but similar to data from two Asian countries. Similar studies from other countries will help ascertain if these differences in prevalence can be attributed to ethnic differences.
- 7 September 2022
- Published by Medknow in Urology Annals
- Vol. 14 (4) , 365-371
Open AccessAdult renal angiomyolipomas: A retrospective analysis of the histological subtypes and their clinicoradiological correlates
Background: Renal angiomyolipomas (AMLs) are rare, benign mesenchymal tumors of the kidney. Asian data on the prevalence of the subtypes of AMLs and their association with tuberous sclerosis are sparse prompting us to evaluate the clinicopathological characteristics of these tumors. Materials and Methods: We included cases diagnosed from 2001 to 2021 extracting demographic details, clinical presentation, syndromic association with tuberous sclerosis, and preoperative clinicoradiological features from the electronic medical records. Results: Ninety-five cases of adult renal AML were diagnosed among 2402 renal tumors, a prevalence of 3.95%. Forty tumors (42%) were detected incidentally; two patients had life-threatening retroperitoneal hemorrhage. Tuberous sclerosis complex (TSC) was associated with ten cases (10.5%). These patients were a decade younger than those in the non-TSC group (P = 0.008) and had bilateral, multiple, and larger tumors (P = 0.0009, 0.001, and 0.047, respectively). Microscopically, classic and epithelioid subtypes were seen in 87 (91.6%) and 8 cases (8.4%), respectively. Hemorrhage was more common in the epithelioid subtype (P = 0.13). HMB-45, melan-A, and smooth muscle actin immunohistochemistry were useful in cases which lacked the prototypical classic histology and for confirming a diagnosis of epithelioid AML. Conclusions: The prevalence of renal AML in our series was four times higher, and the mean age at diagnosis was a decade earlier than that reported in Western literature but similar to data from two Asian countries. Similar studies from other countries will help ascertain if these differences in prevalence can be attributed to ethnic differences.
- Open Access
- 8 July 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 122, 566-568
Accuracy of Xpert MTB/RIF Ultra for the diagnosis of tuberculosis in adult patients: a retrospective cohort study
- 8 July 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 122, 566-568
Open AccessAccuracy of Xpert MTB/RIF Ultra for the diagnosis of tuberculosis in adult patients: a retrospective cohort study
- 23 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e922-e928
Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation
- 23 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e922-e928
Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation
- 1 May 2022
- Published by Angle Publishing Co., Ltd.
- Vol. 65 (5) , 83-93
Meningiomas - transition from traditional histological grading to molecular profiling in WHO CNS5: A Review
Despite being the most common primary intracranial tumor, meningiomas are classified largely based on histological features. The current system of grading has been shown to be unsatisfactory due to its poor reproducibility as well as the considerable variability within grades. With the increasing availability of genomic and epigenomic profiling, several markers have been suggested to correlate with the location, histological subtype, and clinical behavior of meningiomas. These developments have enabled the development of targeted therapy, as well as individualized use of currently available adjuvant methods. These include copy number alterations (CNAs), specific genetic abnormalities (germline and sporadic), and genome-wide methylation profiles. In this review, we recapitulate the changes in the classification of meningiomas thus far, discuss the various histological subtypes recognized, and present the available literature on the genetic and epigenetic profiles of meningiomas. The recognition and further study of these markers have the potential to usher in an era of personalized therapy in the management of meningiomas, vastly improving outcomes as has been observed in the case of several other tumors.
- 1 May 2022
- Published by Angle Publishing Co., Ltd.
- Vol. 65 (5) , 83-93
Meningiomas - transition from traditional histological grading to molecular profiling in WHO CNS5: A Review
Despite being the most common primary intracranial tumor, meningiomas are classified largely based on histological features. The current system of grading has been shown to be unsatisfactory due to its poor reproducibility as well as the considerable variability within grades. With the increasing availability of genomic and epigenomic profiling, several markers have been suggested to correlate with the location, histological subtype, and clinical behavior of meningiomas. These developments have enabled the development of targeted therapy, as well as individualized use of currently available adjuvant methods. These include copy number alterations (CNAs), specific genetic abnormalities (germline and sporadic), and genome-wide methylation profiles. In this review, we recapitulate the changes in the classification of meningiomas thus far, discuss the various histological subtypes recognized, and present the available literature on the genetic and epigenetic profiles of meningiomas. The recognition and further study of these markers have the potential to usher in an era of personalized therapy in the management of meningiomas, vastly improving outcomes as has been observed in the case of several other tumors.
- 1 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e82-e90
ZFTA (Zinc Finger Translocation Associated) Fusion in Supratentorial Ependymomas: Low Prevalence in South Asians and No Correlation with Survival
- 1 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e82-e90
ZFTA (Zinc Finger Translocation Associated) Fusion in Supratentorial Ependymomas: Low Prevalence in South Asians and No Correlation with Survival
- 20 March 2022
- Published by Elsevier in World Neurosurgery
- Vol. 162, e587-e596
A Comparison of Long-Term Treatment Outcomes Between Giant and Nongiant Craniopharyngiomas
- 20 March 2022
- Published by Elsevier in World Neurosurgery
- Vol. 162, e587-e596
A Comparison of Long-Term Treatment Outcomes Between Giant and Nongiant Craniopharyngiomas